Has Geoffrey Gibney, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,262,287 in general payments to Geoffrey Gibney, MD across 425 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Geoffrey Gibney, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Geoffrey Gibney, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Geoffrey Gibney, MD

Internal Medicine · Washington, DCNPI 1164696878

Payments from drug & device makers

$2,262,287in general payments, 2019–2025

Across 425 payments — averaging $5323.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$807K
E.r. Squibb & Sons, L.L.C.$445K
Exelixis Inc.$253K
Novartis$221K
Iovance Biotherapeutics, Inc.$157K
Incyte Corporation$119K
plus $261K from 15 others

$2,630in research payments, 2019–2025

Across 1 payment — averaging $2629.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$3K

What the payments were for

Consulting fees$105,54357%
Speaking & faculty fees$55,77530%
Travel & lodging$17,82310%
Food & beverage$5,6433%
Education$110%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	80	$806,512
E.r. Squibb & Sons, L.L.C.	39	$444,969
Exelixis Inc.	6	$252,639
Novartis	33	$221,012
Iovance Biotherapeutics, Inc.	19	$157,019
Incyte Corporation	73	$119,470
Modernatx, Inc.	12	$80,249
Immunocore Limited	120	$75,491
Genentech, Inc.	7	$74,415
Regeneron	16	$13,114
Regeneron Healthcare Solutions, Inc.	2	$5,895
Eisai Inc.	3	$4,685
Organon	1	$2,700
Genentech USA, Inc.	2	$2,072
Array Biopharma Inc	4	$1,672
Caris MPI, Inc.	1	$191
Beone Medicines USA, Inc.	3	$77
Daiichi Sankyo Inc.	1	$29
Johnson & Johnson	1	$28
GSK	1	$28
Accord Healthcare, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KIMMTRAK$74,194
MEKINIST$24,246
LIBTAYO$18,537
TAFINLAR$17,459
LENVIMA$4,685
OPDIVO$4,680
Amtagvi$3,640
Erivedge$1,980
BRAFTOVI$1,575
KEYTRUDA$590
Cabometyx$336
MI CANCER SEEK$191

How this compares

$2,262,287 in reported general payments places this provider in the 95th percentile of 645 internal medicine providers in District of Columbia.

See all internal medicine providers in District of Columbia →

Medicare billing

Part B allowed, 2024

$58,890

Medicare patients

131

Services billed

448

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Washington

Federico AschWashington$4.6M
Nnemdi Kamanu EliasWashington$939K
Andrea SingerWashington$930K
Kathryn SowerwineWashington$831K
Douglas WardWashington$454K
Ida BergstromWashington$295K
Miriam CameronWashington$290K
Bruce RashbaumWashington$265K
Kevin GriffithsWashington$180K
Maryam Sarraf YazdyWashington$165K

See the full list for District of Columbia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →